RA Research, Resources, and Rheumatology Archives | Page 13 of 19 | Rheumatoid Arthritis Warrior

RA Research, Resources, and Rheumatology

Tofacitinib / CP-690550 aka Tasocitinib Succeeds in Pfizer’s 2nd Phase 3 Trial

Kelly O'Neill 14 Comments , ,
A new name and new milestone for tofacitinib Pfizer announced Friday that CP-690550 tofacitinib (formerly tasocitinib) met its goals in its second phase three clinical trial for moderate to severe Rheumatoid Arthritis. Tofacitinib is a JAK 3 inhibitor, an oral treatment for RA with a different approach than current Biologic RA treatments. According to Pfizer, over 4,000...Continue reading      14 Comments » Read more

Susceptibility for Rheumatoid Arthritis Acquired via Microchimerism?

Kelly O'Neill 24 Comments ,
Women with RA ask why it’s so common to acquire severe Rheumatoid Arthritis after pregnancy the way I did. I don’t blame my son since my symptoms went back years, but these studies are fascinating… Rheumatoid Arthritis HLA shared epitope may be acquired in pregnancy The current issue of Arthritis and Rheumatism brings a study which concludes...Continue reading      24 Comments » Read more

Predicting Rheumatoid Arthritis

Kelly O'Neill 27 Comments , ,
Two new studies indicate that predicting Rheumatoid Arthritis disease activity might be within the realm of possibility. I think Rheumatoid Arthritis lives secretly within the bodies of many victims for years, like a haunting. Invisible activity in a person's cells precedes diagnosis and many patients’ onset stories tell of years of suspicious symptoms. New studies give hope of...Continue reading      27 Comments » Read more

New Rheumatoid Arthritis Remission Criteria

Kelly O'Neill 17 Comments , ,
One of the most fascinating things at ACR last November was the multi-presentation session on the last day focusing on creating Rheumatoid Arthritis remission criteria. We literally sat on the edge of our seats and took notes about the assorted characterizations of RA remission that have been used concurrently over the last couple of decades,...Continue reading      17 Comments » Read more

Perception, Reputation, & Information: How Do We Decide about Dangerous Drugs?

Kelly O'Neill 60 Comments ,
Widespread mis-information on methotrexate In an article in The Rheumatologist, Dr. Bruce Cronstein writes about his frustration with misinformation online about methotrexate. He wonders aloud whether there is some intentional campaign against it. I guess many websites paint an ominous picture of the sunny yellow liquid – or pills – we love to hate. There are...Continue reading      60 Comments » Read more

Rheumatoid Arthritis News, Vol.5: Men & Mortality, Vitamin D Research, New RA Meds

Kelly O'Neill 12 Comments , , , ,
Here are a couple of the Rheumatoid Arthritis news articles that have caught my eye recently or, in some cases, caused me to roll my eyes. More Rheumatoid Arthritis news worth mentioning 1) Big news w/Rheumatoid Arthritis in men:methotrexate fights mortality A study published last month found “men with rheumatoid arthritis were more than twice as likely to...Continue reading      12 Comments » Read more

Nuclear Bone Scans for Rheumatoid Arthritis or Scintigraphy

Kelly O'Neill 40 Comments , ,
Bone scans for Rheumatoid Arthritis that “Lit up like a Christmas tree”! Several patients have told me stories of having a nuclear bone scan (scintigraphy) that made a difference in their diagnosis or treatment. We know how much a reliable imaging tool is needed measuring disease activity for either reason. I’ve read about different versions of...Continue reading      40 Comments » Read more
“imaware™
    Advertisement

Would You Like Free Email Updates?

Stay in touch with RA Warrior.

We respect your privacy. Your email address will never be shared.